<DOC>
	<DOCNO>NCT01804088</DOCNO>
	<brief_summary>The FORMAT Clinical Study clinical trial evaluate safety effectiveness Formula™ 535 Iliac Balloon-Expandable Stent treatment symptomatic vascular disease iliac artery .</brief_summary>
	<brief_title>FORMAT Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>Up two documented common external iliac artery lesion ( one side ) , &gt; 50 % diameter stenosis , suitable stenting iliac artery reference vessel diameter 510 mm Rutherford Category 1 , 2 , 3 , 4 . Less 18 year age lesion site &lt; 10 &gt; 100 mm length external iliac artery lesion visually estimate 100 % occlude presence infrarenal aortic aneurysm &gt; 4 cm ( treat untreated ) presence aneurysm ( treat untreated ) within target vessel significant stenosis ( &gt; 50 % ) occlusion inflow tract ( infrarenal aortic lesion ) successfully treat procedure ( success measure &lt; 30 % residual stenosis ) absence least one patent runoff vessel ≤ 50 % stenosis throughout course ( i.e. , confirmed inline patency level foot ) angiographically evident thrombus within target vessel ( treat untreated ) lesion iliac artery previously stented</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Peripheral artery disease</keyword>
	<keyword>Iliac artery</keyword>
	<keyword>Balloon-expandable stent</keyword>
</DOC>